- Home
- Clinical Trials
Bronchiectasis Studies Pukekohe
Bronchiectasis Study
Pukekohe Auckland
Do you have Bronchiectasis (a chronic lung condition) with frequent flare-ups?
You may be eligible to join a clinical research study investigating a potential new treatment aimed at reducing flare ups, improving symptoms, and supporting better lung health.
By taking part, you may gain early access to potential new treatment options, receive regular health checks, and contribute to medical research that could benefit thousands of people in the future.
Description
What to expect
Study details
Ages
18 to 85 years old
Duration
The study lasts up to 48 weeks, with up to 12 scheduled clinic visits
Compensation
Participants will receive all study-related care at no cost and will be compensated
Eligibility Criteria
You may qualify for this study if you:
- Are aged 18 to 85 years old
- Have a diagnosis of Bronchiectasis (not caused by cystic fibrosis)
- Have ongoing symptoms (such as cough, sputum, or breathlessness) OR have had flare-ups in the past year despite your current treatment
- Are a non-smoker or quit smoking at least 6 months ago
Other criteria apply. A member of our team will check if this study is a good fit for you.
Locations
Description
Bronchiectasis is a chronic lung condition that affects the airways. It is a serious and often debilitating condition that makes it harder for people to breathe and fight off lung infections.
Normal function of the lungs is disrupted, leading to a build-up of mucus that is difficult to clear. Over time, this cycle of infection and damage worsens, making the airways even more prone to problems.
Current treatment often includes antibiotics, therapies to clear mucus, or anti-inflammatory medicines, but for many people this is not enough. However, there are no current treatments in New Zealand that address the underlying inflammation effectively.
This study is investigating a potential new treatment that aims to target inflammation in the lungs through blocking a pathway called IL-33. The hope is that this treatment can potentially reduce the number of flare-ups, improve quality of life, and provide a new option for those living with Bronchiectasis.
What to expect
Participants will be randomly assigned to receive an injection every 12 weeks, with 60% of participants receiving the investigational treatment and 40% receiving a placebo (an inactive treatment).
You’ll attend regular clinic visits for health assessments, including blood pressure monitoring, kidney function tests, and general health check-ups.
Our professional clinical team will closely monitor your health and safety throughout the study and follow up period.
Why join this clinical research study?
- Contribute to research that could improve care for others living with Bronchiectasis
- Receive health checks and monitoring from our professional clinical team
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.